Daptomycin Activity against Uncommonly Isolated Streptococcal and Other Gram-Positive Species Groups

Documenti analoghi

• Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) as Determined by the Revised Susceptibility Testing Method
  di: Mendes, Rodrigo E., et al.
  Pubblicazione: (2014)
• Antimicrobial Activity of Ceftaroline Tested against Staphylococci with Reduced Susceptibility to Linezolid, Daptomycin, or Vancomycin from U.S. Hospitals, 2008 to 2011
  di: Sader, Helio S., et al.
  Pubblicazione: (2013)
• Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Organisms Collected from U.S. Medical Centers in 2012
  di: Sader, Helio S., et al.
  Pubblicazione: (2014)
• Worldwide Appraisal and Update (2010) of Telavancin Activity Tested against a Collection of Gram-Positive Clinical Pathogens from Five Continents
  di: Mendes, Rodrigo E., et al.
  Pubblicazione: (2012)
• Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014
  di: Sader, Helio S., et al.
  Pubblicazione: (2016)